Melatonin

Last Updated: September 28 2022

Melatonin is a hormone secreted in the brain that regulates sleep. It appears to be highly sensitive to Light Therapy and Dark Therapy. Oral ingestion of melatonin may be used as a sleep aid. It is non-addictive.

Melatonin is most often used for

What is melatonin?

Melatonin is a neurohormone secreted by the pineal gland in the brain and it is well known for causing and regulating sleep. Light suppresses melatonin synthesis. The primary use of melatonin as a supplement is to normalize abnormal sleep patterns.

What are melatonin’s main benefits?

Irregular sleep patterns are associated with a wide variety of health problems and premature aging. Melatonin is the hormone used by your body to help you fall asleep, and thus supplementation is seen as a way to get regular sleep. This is particularly useful for people who engage in shift work or are jet lagged.

Melatonin may also have general neuroprotective effects, related to its antioxidant effects. Melatonin also has several anti-cancer properties, and is currently being investigated for its role in fighting breast cancer, although human studies on the topic are lacking.

Melatonin does not appear to have much of an effect on lean mass or body fat, but potentially stops your body from gaining more fat. Melatonin supplementation also benefits gastric (somach) health, possibly reduces tinnitus, and improve mood (by helping you get better sleep).

There are some demographics that tend to have irregular melatonin production in their body. Smokers tend to be less responsive to supplementation, and older people tend to not produce as much during night time. Depression has also been associated with lower melatonin levels.

What are melatonin’s main drawbacks?

In typical dosages, melatonin appears fairly safe. Side effects are both uncommon and usually mild, including daytime sleepiness, headache, and nausea. Very rarely, serious adverse effects resulting from melatonin supplementation (often in very high doses) have been reported.

Taking melatonin is not associated with negative feedback (when taking supplementation causes your body to produce less of a hormone). It is also not addictive.

How does melatonin work?

Melatonin’s primary mechanism is by helping decrease the time it takes to fall asleep (as a hormone, that's its primary job).

What else is Melatonin known as?
Note that Melatonin is also known as:
  • N-Acetyl-5-Methoxytryptamine
  • Melatonine
  • Melovine
  • Melatol
  • Melatonex
  • Circadin
Dosage information

For regulating the sleep cycle, doses of melatonin between 500mcg (0.5mg) and 5mg seem to work. Start with 500mcg, and if it doesn’t work, work up to 3-5mg. The benefits of melatonin are not dose-dependent - taking more will not help you fall asleep faster.

To help with sleep, take roughly 30 minutes before going to bed.

Growth hormone appears to spike slightly better at 5mg than 500mcg, although both doses are fairly effective.

Join our supplement information course

Become an Examine Insider for FREE and get a full five-day mini course on supplements. 100% backed by science, we take an independent and unbiased approach to figure out what works (and what's a waste of time and money).

    The only 100% independent company. While everyone sells supplements, we only analyze research.

    Examine Database
    What works and what doesn't?

    Unlock the full potential of Examine

    Get started

    Don't miss out on the latest research

    Become an Examine Insider for FREE to stay on top of the latest nutrition research, supplement myths, and more

      References
      1.^Hattori A, Migitaka H, Iigo M, Itoh M, Yamamoto K, Ohtani-Kaneko R, Hara M, Suzuki T, Reiter RJIdentification of melatonin in plants and its effects on plasma melatonin levels and binding to melatonin receptors in vertebratesBiochem Mol Biol Int.(1995 Mar)
      2.^Peuhkuri K, Sihvola N, Korpela RDietary factors and fluctuating levels of melatoninFood Nutr Res.(2012)
      3.^Tan DX, Hardeland R, Manchester LC, Korkmaz A, Ma S, Rosales-Corral S, Reiter RJFunctional roles of melatonin in plants, and perspectives in nutritional and agricultural scienceJ Exp Bot.(2012 Jan)
      4.^Iriti M, Varoni EM, Vitalini SMelatonin in traditional Mediterranean dietsJ Pineal Res.(2010 Sep)
      10.^Valtonen M, Niskanen L, Kangas AP, Koskinen TEffect of melatonin-rich night-time milk on sleep and activity in elderly institutionalized subjectsNord J Psychiatry.(2005)
      13.^Burkhardt S, Tan DX, Manchester LC, Hardeland R, Reiter RJDetection and quantification of the antioxidant melatonin in Montmorency and Balaton tart cherries (Prunus cerasus)J Agric Food Chem.(2001 Oct)
      14.^Chen G, Huo Y, Tan DX, Liang Z, Zhang W, Zhang YMelatonin in Chinese medicinal herbsLife Sci.(2003 May 23)
      15.^Sanchez-Hidalgo M, Lu Z, Tan DX, Maldonado MD, Reiter RJ, Gregerman RIMelatonin inhibits fatty acid-induced triglyceride accumulation in ROS17/2.8 cells: implications for osteoblast differentiation and osteoporosisAm J Physiol Regul Integr Comp Physiol.(2007 Jun)
      16.^Bernard M, Guerlotté J, Grève P, Gréchez-Cassiau A, Iuvone MP, Zatz M, Chong NW, Klein DC, Voisin PMelatonin synthesis pathway: circadian regulation of the genes encoding the key enzymes in the chicken pineal gland and retinaReprod Nutr Dev.(1999 May-Jun)
      18.^Bubenik GA, Konturek SJMelatonin and aging: prospects for human treatmentJ Physiol Pharmacol.(2011 Feb)
      19.^Kollmann MT, Locher M, Hirche F, Eder K, Meyer HH, Bruckmaier RMEffects of tryptophan supplementation on plasma tryptophan and related hormone levels in heifers and dairy cowsDomest Anim Endocrinol.(2008 Jan)
      22.^Klein DCArylalkylamine N-acetyltransferase: "the Timezyme"J Biol Chem.(2007 Feb 16)
      25.^Wright J, Aldhous M, Franey C, English J, Arendt JThe effects of exogenous melatonin on endocrine function in manClin Endocrinol (Oxf).(1986 Apr)
      26.^Arendt J, Bojkowski C, Folkard S, Franey C, Marks V, Minors D, Waterhouse J, Wever RA, Wildgruber C, Wright JSome effects of melatonin and the control of its secretion in humansCiba Found Symp.(1985)
      27.^Hack LM, Lockley SW, Arendt J, Skene DJThe effects of low-dose 0.5-mg melatonin on the free-running circadian rhythms of blind subjectsJ Biol Rhythms.(2003 Oct)
      32.^Wetterberg L, Bergiannaki JD, Paparrigopoulos T, von Knorring L, Eberhard G, Bratlid T, Yuwiler ANormative melatonin excretion: a multinational studyPsychoneuroendocrinology.(1999 Feb)
      33.^Benot S, Goberna R, Reiter RJ, Garcia-Mauriño S, Osuna C, Guerrero JMPhysiological levels of melatonin contribute to the antioxidant capacity of human serumJ Pineal Res.(1999 Aug)
      34.^Pandi-Perumal SR, Zisapel N, Srinivasan V, Cardinali DPMelatonin and sleep in aging populationExp Gerontol.(2005 Dec)
      36.^Nagata C, Nagao Y, Shibuya C, Kashiki Y, Shimizu HAssociation of vegetable intake with urinary 6-sulfatoxymelatonin levelCancer Epidemiol Biomarkers Prev.(2005 May)
      37.^Michalsen A, Schlegel F, Rodenbeck A, Lüdtke R, Huether G, Teschler H, Dobos GJEffects of short-term modified fasting on sleep patterns and daytime vigilance in non-obese subjects: results of a pilot studyAnn Nutr Metab.(2003)
      38.^Röjdmark S, Rössner S, Wetterberg LEffect of short-term fasting on nocturnal melatonin secretion in obesityMetabolism.(1992 Oct)
      39.^Röjdmark S, Wetterberg LShort-term fasting inhibits the nocturnal melatonin secretion in healthy manClin Endocrinol (Oxf).(1989 Apr)
      40.^Stokkan KA, Reiter RJ, Vaughan MK, Nonaka KO, Lerchl AEndocrine and metabolic effects of life-long food restriction in ratsActa Endocrinol (Copenh).(1991 Jul)
      41.^Beck-Friis J, von Rosen D, Kjellman BF, Ljunggren JG, Wetterberg LMelatonin in relation to body measures, sex, age, season and the use of drugs in patients with major affective disorders and healthy subjectsPsychoneuroendocrinology.(1984)
      42.^Tarquini B, Perfetto F, Poli R, Tarquini RDaytime circulating melatonin levels in smokersTumori.(1994 Jun 30)
      43.^Ozguner F, Koyu A, Cesur GActive smoking causes oxidative stress and decreases blood melatonin levelsToxicol Ind Health.(2005 Mar)
      44.^Ursing C, von Bahr C, Brismar K, Röjdmark SInfluence of cigarette smoking on melatonin levels in manEur J Clin Pharmacol.(2005 May)
      45.^Schrenk D, Brockmeier D, Mörike K, Bock KW, Eichelbaum MA distribution study of CYP1A2 phenotypes among smokers and nonsmokers in a cohort of healthy Caucasian volunteersEur J Clin Pharmacol.(1998 Jan)
      48.^Korkushko OV, Khavinson VKh, Shatilo VB, Antonyk-Sheglova IAPeptide geroprotector from the pituitary gland inhibits rapid aging of elderly people: results of 15-year follow-upBull Exp Biol Med.(2011 Jul)
      49.^Mixon MB, Lee E, Coleman DE, Berghuis AM, Gilman AG, Sprang SRTertiary and quaternary structural changes in Gi alpha 1 induced by GTP hydrolysisScience.(1995 Nov 10)
      50.^Dubocovich ML, Markowska MFunctional MT1 and MT2 melatonin receptors in mammalsEndocrine.(2005 Jul)
      51.^Reppert SM, Weaver DR, Godson CMelatonin receptors step into the light: cloning and classification of subtypesTrends Pharmacol Sci.(1996 Mar)
      52.^Roca AL, Godson C, Weaver DR, Reppert SMStructure, characterization, and expression of the gene encoding the mouse Mel1a melatonin receptorEndocrinology.(1996 Aug)
      54.^Slaugenhaupt SA, Roca AL, Liebert CB, Altherr MR, Gusella JF, Reppert SMMapping of the gene for the Mel1a-melatonin receptor to human chromosome 4 (MTNR1A) and mouse chromosome 8 (Mtnr1a)Genomics.(1995 May 20)
      55.^Dubocovich ML, Rivera-Bermudez MA, Gerdin MJ, Masana MIMolecular pharmacology, regulation and function of mammalian melatonin receptorsFront Biosci.(2003 Sep 1)
      56.^Masana MI, Dubocovich MLMelatonin receptor signaling: finding the path through the darkSci STKE.(2001 Nov 6)
      58.^Nosjean O, Ferro M, Coge F, Beauverger P, Henlin JM, Lefoulon F, Fauchere JL, Delagrange P, Canet E, Boutin JAIdentification of the melatonin-binding site MT3 as the quinone reductase 2J Biol Chem.(2000 Oct 6)
      59.^Nosjean O, Nicolas JP, Klupsch F, Delagrange P, Canet E, Boutin JAComparative pharmacological studies of melatonin receptors: MT1, MT2 and MT3/QR2. Tissue distribution of MT3/QR2Biochem Pharmacol.(2001 Jun 1)
      61.^Becker-André M, Wiesenberg I, Schaeren-Wiemers N, André E, Missbach M, Saurat JH, Carlberg CPineal gland hormone melatonin binds and activates an orphan of the nuclear receptor superfamilyJ Biol Chem.(1994 Nov 18)
      62.^Yasuo S, Yoshimura T, Ebihara S, Korf HWMelatonin transmits photoperiodic signals through the MT1 melatonin receptorJ Neurosci.(2009 Mar 4)
      63.^Ishii H, Tanaka N, Kobayashi M, Kato M, Sakuma YGene structures, biochemical characterization and distribution of rat melatonin receptorsJ Physiol Sci.(2009 Jan)
      65.^Kazantzis M, Takahashi V, Hinkle J, Kota S, Zilberfarb V, Issad T, Abdelkarim M, Chouchane L, Strosberg ADPAZ6 cells constitute a representative model for human brown pre-adipocytesFront Endocrinol (Lausanne).(2012)
      66.^Reppert SM, Weaver DR, Ebisawa T, Mahle CD, Kolakowski LF JrCloning of a melatonin-related receptor from human pituitaryFEBS Lett.(1996 May 20)
      67.^Bechtold DA, Sidibe A, Saer BR, Li J, Hand LE, Ivanova EA, Darras VM, Dam J, Jockers R, Luckman SM, Loudon ASA role for the melatonin-related receptor GPR50 in leptin signaling, adaptive thermogenesis, and torporCurr Biol.(2012 Jan 10)
      68.^Sidibe A, Mullier A, Chen P, Baroncini M, Boutin JA, Delagrange P, Prevot V, Jockers RExpression of the orphan GPR50 protein in rodent and human dorsomedial hypothalamus, tanycytes and median eminenceJ Pineal Res.(2010 Apr)
      69.^Ivanova EA, Bechtold DA, Dupré SM, Brennand J, Barrett P, Luckman SM, Loudon ASAltered metabolism in the melatonin-related receptor (GPR50) knockout mouseAm J Physiol Endocrinol Metab.(2008 Jan)
      71.^Jockers R, Maurice P, Boutin JA, Delagrange PMelatonin receptors, heterodimerization, signal transduction and binding sites: what's newBr J Pharmacol.(2008 Jul)
      72.^Levoye A, Dam J, Ayoub MA, Guillaume JL, Couturier C, Delagrange P, Jockers RThe orphan GPR50 receptor specifically inhibits MT1 melatonin receptor function through heterodimerizationEMBO J.(2006 Jul 12)
      73.^Mundey K, Benloucif S, Harsanyi K, Dubocovich ML, Zee PCPhase-dependent treatment of delayed sleep phase syndrome with melatoninSleep.(2005 Oct)
      76.^Sack RL, Brandes RW, Kendall AR, Lewy AJEntrainment of free-running circadian rhythms by melatonin in blind peopleN Engl J Med.(2000 Oct 12)
      77.^Dawson D, Gibbon S, Singh PThe hypothermic effect of melatonin on core body temperature: is more betterJ Pineal Res.(1996 May)
      78.^Meeking DR, Wallace JD, Cuneo RC, Forsling M, Russell-Jones DLExercise-induced GH secretion is enhanced by the oral ingestion of melatonin in healthy adult male subjectsEur J Endocrinol.(1999 Jul)
      79.^Mero AA, Vähälummukka M, Hulmi JJ, Kallio P, von Wright AEffects of resistance exercise session after oral ingestion of melatonin on physiological and performance responses of adult menEur J Appl Physiol.(2006 Apr)
      80.^Cagnacci A, Soldani R, Yen SSMelatonin enhances cortisol levels in aged women: reversible by estrogensJ Pineal Res.(1997 Mar)
      81.^Cagnacci A, Elliott JA, Yen SSAmplification of pulsatile LH secretion by exogenous melatonin in womenJ Clin Endocrinol Metab.(1991 Jul)
      82.^Waldhauser F, Waldhauser M, Lieberman HR, Deng MH, Lynch HJ, Wurtman RJBioavailability of oral melatonin in humansNeuroendocrinology.(1984 Oct)
      83.^Markantonis SL, Tsakalozou E, Paraskeva A, Staikou C, Fassoulaki AMelatonin pharmacokinetics in premenopausal and postmenopausal healthy female volunteersJ Clin Pharmacol.(2008 Feb)
      85.^Bechgaard E, Lindhardt K, Martinsen LIntranasal absorption of melatonin in vivo bioavailability studyInt J Pharm.(1999 May 10)
      86.^Ma X, Idle JR, Krausz KW, Gonzalez FJMetabolism of melatonin by human cytochromes p450Drug Metab Dispos.(2005 Apr)
      87.^Facciolá G, Hidestrand M, von Bahr C, Tybring GCytochrome P450 isoforms involved in melatonin metabolism in human liver microsomesEur J Clin Pharmacol.(2001 Mar)
      88.^Skene DJ, Papagiannidou E, Hashemi E, Snelling J, Lewis DF, Fernandez M, Ioannides CContribution of CYP1A2 in the hepatic metabolism of melatonin: studies with isolated microsomal preparations and liver slicesJ Pineal Res.(2001 Nov)
      89.^Ma X, Idle JR, Krausz KW, Gonzalez FJMetabolism of melatonin by human cytochromes p450Drug Metab Dispos.(2005 Apr)
      90.^Grözinger M, Härtter S, Wang X, Röschke J, Hiemke C, Rose DMFluvoxamine strongly inhibits melatonin metabolism in a patient with low-amplitude melatonin profileArch Gen Psychiatry.(2000 Aug)
      91.^Härtter S, Grözinger M, Weigmann H, Röschke J, Hiemke CIncreased bioavailability of oral melatonin after fluvoxamine coadministrationClin Pharmacol Ther.(2000 Jan)
      92.^Rimmele U, Spillmann M, Bärtschi C, Wolf OT, Weber CS, Ehlert U, Wirtz PHMelatonin improves memory acquisition under stress independent of stress hormone releasePsychopharmacology (Berl).(2009 Mar)
      93.^Arangino S, Cagnacci A, Angiolucci M, Vacca AM, Longu G, Volpe A, Melis GBEffects of melatonin on vascular reactivity, catecholamine levels, and blood pressure in healthy menAm J Cardiol.(1999 May 1)
      94.^Nishiyama K, Yasue H, Moriyama Y, Tsunoda R, Ogawa H, Yoshimura M, Kugiyama KAcute effects of melatonin administration on cardiovascular autonomic regulation in healthy menAm Heart J.(2001 May)
      95.^Cagnacci A, Arangino S, Angiolucci M, Maschio E, Melis GBInfluences of melatonin administration on the circulation of womenAm J Physiol.(1998 Feb)
      99.^Escames G, Macías M, León J, García J, Khaldy H, Martín M, Vives F, Acuña-Castroviejo DCalcium-dependent effects of melatonin inhibition of glutamatergic response in rat striatumJ Neuroendocrinol.(2001 May)
      104.^Jin X, von Gall C, Pieschl RL, Gribkoff VK, Stehle JH, Reppert SM, Weaver DRTargeted disruption of the mouse Mel(1b) melatonin receptorMol Cell Biol.(2003 Feb)
      105.^von Gall C, Weaver DR, Kock M, Korf HW, Stehle JHMelatonin limits transcriptional impact of phosphoCREB in the mouse SCN via the Mel1a receptorNeuroreport.(2000 Jun 26)
      107.^Kunz D, Mahlberg R, Müller C, Tilmann A, Bes FMelatonin in patients with reduced REM sleep duration: two randomized controlled trialsJ Clin Endocrinol Metab.(2004 Jan)
      109.^Dubocovich ML, Hudson RL, Sumaya IC, Masana MI, Manna EEffect of MT1 melatonin receptor deletion on melatonin-mediated phase shift of circadian rhythms in the C57BL/6 mouseJ Pineal Res.(2005 Sep)
      111.^Shibata S, Cassone VM, Moore RYEffects of melatonin on neuronal activity in the rat suprachiasmatic nucleus in vitroNeurosci Lett.(1989 Feb 13)
      112.^Liu C, Weaver DR, Jin X, Shearman LP, Pieschl RL, Gribkoff VK, Reppert SMMolecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clockNeuron.(1997 Jul)
      113.^Forsling ML, Williams AJThe effect of exogenous melatonin on stimulated neurohypophysial hormone release in manClin Endocrinol (Oxf).(2002 Nov)
      114.^Forsling ML, Wheeler MJ, Williams AJThe effect of melatonin administration on pituitary hormone secretion in manClin Endocrinol (Oxf).(1999 Nov)
      115.^Kostoglou-Athanassiou I, Treacher DF, Wheeler MJ, Forsling MLMelatonin administration and pituitary hormone secretionClin Endocrinol (Oxf).(1998 Jan)
      116.^Wang JZ, Wang ZFRole of melatonin in Alzheimer-like neurodegenerationActa Pharmacol Sin.(2006 Jan)
      122.^Alstadhaug K, Salvesen R, Bekkelund S24-hour distribution of migraine attacksHeadache.(2008 Jan)
      123.^Alstadhaug K, Salvesen R, Bekkelund SInsomnia and circadian variation of attacks in episodic migraineHeadache.(2007 Sep)
      124.^Alstadhaug KB, Odeh F, Salvesen R, Bekkelund SIProphylaxis of migraine with melatonin: a randomized controlled trialNeurology.(2010 Oct 26)
      125.^Peres MFMelatonin for migraine preventionCurr Pain Headache Rep.(2011 Oct)
      127.^Ferini-Strambi L, Zucconi M, Biella G, Stankov B, Fraschini F, Oldani A, Smirne SEffect of melatonin on sleep microstructure: preliminary results in healthy subjectsSleep.(1993 Dec)
      128.^James SP, Mendelson WB, Sack DA, Rosenthal NE, Wehr TAThe effect of melatonin on normal sleepNeuropsychopharmacology.(1987 Dec)
      129.^Cramer H, Rudolph J, Consbruch U, Kendel KOn the effects of melatonin on sleep and behavior in manAdv Biochem Psychopharmacol.(1974)
      130.^Waldhauser F, Saletu B, Trinchard-Lugan ISleep laboratory investigations on hypnotic properties of melatoninPsychopharmacology (Berl).(1990)
      132.^Nave R, Peled R, Lavie PMelatonin improves evening nappingEur J Pharmacol.(1995 Mar 6)
      133.^Reid K, Van den Heuvel C, Dawson DDay-time melatonin administration: effects on core temperature and sleep onset latencyJ Sleep Res.(1996 Sep)
      134.^Zhdanova IV, Wurtman RJ, Lynch HJ, Ives JR, Dollins AB, Morabito C, Matheson JK, Schomer DLSleep-inducing effects of low doses of melatonin ingested in the eveningClin Pharmacol Ther.(1995 May)
      135.^Zhdanova IV, Wurtman RJ, Morabito C, Piotrovska VR, Lynch HJEffects of low oral doses of melatonin, given 2-4 hours before habitual bedtime, on sleep in normal young humansSleep.(1996 Jun)
      138.^Wade AG, Crawford G, Ford I, McConnachie A, Nir T, Laudon M, Zisapel NProlonged release melatonin in the treatment of primary insomnia: evaluation of the age cut-off for short- and long-term responseCurr Med Res Opin.(2011 Jan)
      142.^Marshall WA, Tanner JMVariations in the pattern of pubertal changes in boysArch Dis Child.(1970 Feb)
      143.^Marshall WA, Tanner JMVariations in pattern of pubertal changes in girlsArch Dis Child.(1969 Jun)
      144.^Hurtuk A, Dome C, Holloman CH, Wolfe K, Welling DB, Dodson EE, Jacob AMelatonin: can it stop the ringingAnn Otol Rhinol Laryngol.(2011 Jul)
      145.^Requintina PJ, Oxenkrug GF, Yuwiler A, Oxenkrug AGSynergistic sedative effect of selective MAO-A, but not MAO-B, inhibitors and melatonin in frogsJ Neural Transm Suppl.(1994)
      146.^Rajaratnam SM, Arendt JHealth in a 24-h societyLancet.(2001 Sep 22)
      150.^Herxheimer A, Petrie KJMelatonin for the prevention and treatment of jet lagCochrane Database Syst Rev.(2002)
      151.^Spitzer RL, Terman M, Williams JB, Terman JS, Malt UF, Singer F, Lewy AJJet lag: clinical features, validation of a new syndrome-specific scale, and lack of response to melatonin in a randomized, double-blind trialAm J Psychiatry.(1999 Sep)
      152.^Suhner A, Schlagenhauf P, Höfer I, Johnson R, Tschopp A, Steffen REffectiveness and tolerability of melatonin and zolpidem for the alleviation of jet lagAviat Space Environ Med.(2001 Jul)
      153.^Beaumont M, Batéjat D, Piérard C, Van Beers P, Denis JB, Coste O, Doireau P, Chauffard F, French J, Lagarde DCaffeine or melatonin effects on sleep and sleepiness after rapid eastward transmeridian travelJ Appl Physiol.(2004 Jan)
      154.^Petrie K, Dawson AG, Thompson L, Brook RA double-blind trial of melatonin as a treatment for jet lag in international cabin crewBiol Psychiatry.(1993 Apr 1)
      155.^Claustrat B, Brun J, David M, Sassolas G, Chazot GMelatonin and jet lag: confirmatory result using a simplified protocolBiol Psychiatry.(1992 Oct 15)
      156.^Piérard C, Beaumont M, Enslen M, Chauffard F, Tan DX, Reiter RJ, Fontan A, French J, Coste O, Lagarde DResynchronization of hormonal rhythms after an eastbound flight in humans: effects of slow-release caffeine and melatoninEur J Appl Physiol.(2001 Jul)
      157.^Edwards BJ, Atkinson G, Waterhouse J, Reilly T, Godfrey R, Budgett RUse of melatonin in recovery from jet-lag following an eastward flight across 10 time-zonesErgonomics.(2000 Oct)
      158.^Sharkey KM, Eastman CIMelatonin phase shifts human circadian rhythms in a placebo-controlled simulated night-work studyAm J Physiol Regul Integr Comp Physiol.(2002 Feb)
      159.^Samel A, Wegmann HM, Vejvoda M, Maass H, Gundel A, Schütz MInfluence of melatonin treatment on human circadian rhythmicity before and after a simulated 9-hr time shiftJ Biol Rhythms.(1991 Fall)
      160.^Paul MA, Gray GW, Lieberman HR, Love RJ, Miller JC, Trouborst M, Arendt JPhase advance with separate and combined melatonin and light treatmentPsychopharmacology (Berl).(2011 Mar)
      162.^Revell VL, Burgess HJ, Gazda CJ, Smith MR, Fogg LF, Eastman CIAdvancing human circadian rhythms with afternoon melatonin and morning intermittent bright lightJ Clin Endocrinol Metab.(2006 Jan)
      163.^Wirz-Justice A, Kräuchi K, Cajochen C, Danilenko KV, Renz C, Weber JMEvening melatonin and bright light administration induce additive phase shifts in dim light melatonin onsetJ Pineal Res.(2004 Apr)
      164.^Kitaoka K, Uchida K, Okamoto N, Chikahisa S, Miyazaki T, Takeda E, Séi HFermented ginseng improves the first-night effect in humansSleep.(2009 Mar)
      166.^Shamir E, Rotenberg VS, Laudon M, Zisapel N, Elizur AFirst-night effect of melatonin treatment in patients with chronic schizophreniaJ Clin Psychopharmacol.(2000 Dec)
      167.^Shamir E, Laudon M, Barak Y, Anis Y, Rotenberg V, Elizur A, Zisapel NMelatonin improves sleep quality of patients with chronic schizophreniaJ Clin Psychiatry.(2000 May)
      168.^Lewy AJ, Sack RL, Miller LS, Hoban TMAntidepressant and circadian phase-shifting effects of lightScience.(1987 Jan 16)
      169.^Teicher MH, Glod CA, Magnus E, Harper D, Benson G, Krueger K, McGreenery CECircadian rest-activity disturbances in seasonal affective disorderArch Gen Psychiatry.(1997 Feb)
      170.^Lewy AJ, Lefler BJ, Emens JS, Bauer VKThe circadian basis of winter depressionProc Natl Acad Sci U S A.(2006 May 9)
      171.^Lewy AJ, Bauer VK, Ahmed S, Thomas KH, Cutler NL, Singer CM, Moffit MT, Sack RLThe human phase response curve (PRC) to melatonin is about 12 hours out of phase with the PRC to lightChronobiol Int.(1998 Jan)
      173.^Rondanelli M, Opizzi A, Faliva M, Mozzoni M, Antoniello N, Cazzola R, Savarè R, Cerutti R, Grossi E, Cestaro BEffects of a diet integration with an oily emulsion of DHA-phospholipids containing melatonin and tryptophan in elderly patients suffering from mild cognitive impairmentNutr Neurosci.(2012 Mar)
      175.^Cook JS, Sauder CL, Ray CAMelatonin differentially affects vascular blood flow in humansAm J Physiol Heart Circ Physiol.(2011 Feb)
      176.^Koziróg M, Poliwczak AR, Duchnowicz P, Koter-Michalak M, Sikora J, Broncel MMelatonin treatment improves blood pressure, lipid profile, and parameters of oxidative stress in patients with metabolic syndromeJ Pineal Res.(2011 Apr)
      178.^Celinski K, Konturek SJ, Konturek PC, Brzozowski T, Cichoz-Lach H, Slomka M, Malgorzata P, Bielanski W, Reiter RJMelatonin or L-tryptophan accelerates healing of gastroduodenal ulcers in patients treated with omeprazoleJ Pineal Res.(2011 May)
      179.^Gonciarz M, Bielański W, Partyka R, Brzozowski T, Konturek PC, Eszyk J, Celiński K, Reiter RJ, Konturek SJPlasma insulin, leptin, adiponectin, resistin, ghrelin, and melatonin in nonalcoholic steatohepatitis patients treated with melatoninJ Pineal Res.(2012 Jun 13)
      180.^Ríos-Lugo MJ, Cano P, Jiménez-Ortega V, Fernández-Mateos MP, Scacchi PA, Cardinali DP, Esquifino AIMelatonin effect on plasma adiponectin, leptin, insulin, glucose, triglycerides and cholesterol in normal and high fat-fed ratsJ Pineal Res.(2010 Nov)
      183.^Alonso-Vale MI, Andreotti S, Peres SB, Anhê GF, das Neves Borges-Silva C, Neto JC, Lima FBMelatonin enhances leptin expression by rat adipocytes in the presence of insulinAm J Physiol Endocrinol Metab.(2005 Apr)
      184.^Alonso-Vale MI, Andreotti S, Borges-Silva CN, Mukai PY, Cipolla-Neto J, Lima FBIntermittent and rhythmic exposure to melatonin in primary cultured adipocytes enhances the insulin and dexamethasone effects on leptin expressionJ Pineal Res.(2006 Aug)
      185.^Borges-Silva CN, Fonseca-Alaniz MH, Alonso-Vale MI, Takada J, Andreotti S, Peres SB, Cipolla-Neto J, Pithon-Curi TC, Lima FBReduced lipolysis and increased lipogenesis in adipose tissue from pinealectomized rats adapted to trainingJ Pineal Res.(2005 Sep)
      187.^Alonso-Vale MI, Peres SB, Vernochet C, Farmer SR, Lima FBAdipocyte differentiation is inhibited by melatonin through the regulation of C/EBPbeta transcriptional activityJ Pineal Res.(2009 Oct)
      188.^Zwirska-Korczala K, Jochem J, Adamczyk-Sowa M, Sowa P, Polaniak R, Birkner E, Latocha M, Pilc K, Suchanek RInfluence of melatonin on cell proliferation, antioxidative enzyme activities and lipid peroxidation in 3T3-L1 preadipocytes--an in vitro studyJ Physiol Pharmacol.(2005 Dec)
      191.^Stratos I, Richter N, Rotter R, Li Z, Zechner D, Mittlmeier T, Vollmar BMelatonin restores muscle regeneration and enhances muscle function after crush injury in ratsJ Pineal Res.(2012 Jan)
      192.^Wang WZ, Fang XH, Stephenson LL, Zhang X, Khiabani KT, Zamboni WAMelatonin attenuates I/R-induced mitochondrial dysfunction in skeletal muscleJ Surg Res.(2011 Nov)
      194.^Atkinson G, Buckley P, Edwards B, Reilly T, Waterhouse JAre there hangover-effects on physical performance when melatonin is ingested by athletes before nocturnal sleepInt J Sports Med.(2001 Apr)
      195.^Atkinson G, Jones H, Edwards BJ, Waterhouse JMEffects of daytime ingestion of melatonin on short-term athletic performanceErgonomics.(2005 Sep 15-Nov 15)
      196.^Schernhammer ES, Giobbie-Hurder A, Gantman K, Savoie J, Scheib R, Parker LM, Chen WYA randomized controlled trial of oral melatonin supplementation and breast cancer biomarkersCancer Causes Control.(2012 Apr)
      197.^Cos S, Martínez-Campa C, Mediavilla MD, Sánchez-Barceló EJMelatonin modulates aromatase activity in MCF-7 human breast cancer cellsJ Pineal Res.(2005 Mar)
      198.^González A, Martínez-Campa C, Mediavilla MD, Alonso-González C, Sánchez-Mateos S, Hill SM, Sánchez-Barceló EJ, Cos SEffects of MT1 melatonin receptor overexpression on the aromatase-suppressive effect of melatonin in MCF-7 human breast cancer cellsOncol Rep.(2007 Apr)
      200.^Knower KC, To SQ, Takagi K, Miki Y, Sasano H, Simpson ER, Clyne CDMelatonin suppresses aromatase expression and activity in breast cancer associated fibroblastsBreast Cancer Res Treat.(2012 Apr)
      202.^Dufau ML, Tinajero JC, Fabbri ACorticotropin-releasing factor: an antireproductive hormone of the testisFASEB J.(1993 Feb 1)
      203.^Rossi SP, Matzkin ME, Terradas C, Ponzio R, Puigdomenech E, Levalle O, Calandra RS, Frungieri MBNew insights into melatonin/CRH signaling in hamster Leydig cellsGen Comp Endocrinol.(2012 Aug 1)
      205.^Valcavi R, Zini M, Maestroni GJ, Conti A, Portioli IMelatonin stimulates growth hormone secretion through pathways other than the growth hormone-releasing hormoneClin Endocrinol (Oxf).(1993 Aug)
      207.^Nassar E, Mulligan C, Taylor L, Kerksick C, Galbreath M, Greenwood M, Kreider R, Willoughby DSEffects of a single dose of N-Acetyl-5-methoxytryptamine (Melatonin) and resistance exercise on the growth hormone/IGF-1 axis in young males and femalesJ Int Soc Sports Nutr.(2007 Oct 23)
      209.^Allegra M, Reiter RJ, Tan DX, Gentile C, Tesoriere L, Livrea MAThe chemistry of melatonin's interaction with reactive speciesJ Pineal Res.(2003 Jan)
      211.^Poeggeler B, Saarela S, Reiter RJ, Tan DX, Chen LD, Manchester LC, Barlow-Walden LRMelatonin--a highly potent endogenous radical scavenger and electron donor: new aspects of the oxidation chemistry of this indole accessed in vitroAnn N Y Acad Sci.(1994 Nov 17)
      213.^Noda Y, Mori A, Liburdy R, Packer LMelatonin and its precursors scavenge nitric oxideJ Pineal Res.(1999 Oct)
      216.^Kandil TS, Mousa AA, El-Gendy AA, Abbas AMThe potential therapeutic effect of melatonin in Gastroesophageal Reflux DiseaseBMC Gastroenterol.(2010 Jan 18)
      217.^Celinski K, Konturek PC, Konturek SJ, Slomka M, Cichoz-Lach H, Brzozowski T, Bielanski WEffects of melatonin and tryptophan on healing of gastric and duodenal ulcers with Helicobacter pylori infection in humansJ Physiol Pharmacol.(2011 Oct)
      219.^Konturek PC, Konturek SJ, Celinski K, Slomka M, Cichoz-Lach H, Bielanski W, Reiter RJRole of melatonin in mucosal gastroprotection against aspirin-induced gastric lesions in humansJ Pineal Res.(2010 May)
      221.^Alarma-Estrany P, Crooke A, Mediero A, Peláez T, Pintor JSympathetic nervous system modulates the ocular hypotensive action of MT2-melatonin receptors in normotensive rabbitsJ Pineal Res.(2008 Nov)
      223.^Samples JR, Krause G, Lewy AJEffect of melatonin on intraocular pressureCurr Eye Res.(1988 Jul)
      225.^Crooke A, Huete-Toral F, Martínez-Águila A, Alarma-Estrany P, Pintor JRegulation of ocular adrenoceptor genes expression by 5-MCA-NAT: implications for glaucoma treatmentPharmacogenet Genomics.(2011 Sep)
      226.^Crooke A, Huete-Toral F, Martínez-Águila A, Martín-Gil A, Pintor JInvolvement of carbonic anhydrases in the ocular hypotensive effect of melatonin analogue 5-MCA-NATJ Pineal Res.(2012 Apr)
      227.^Chiquet C, Claustrat B, Thuret G, Brun J, Cooper HM, Denis PMelatonin concentrations in aqueous humor of glaucoma patientsAm J Ophthalmol.(2006 Aug)
      229.^Mediero A, Alarma-Estrany P, Pintor JNew treatments for ocular hypertensionAuton Neurosci.(2009 May 11)
      230.^Yi C, Pan X, Yan H, Guo M, Pierpaoli WEffects of melatonin in age-related macular degenerationAnn N Y Acad Sci.(2005 Dec)
      231.^Rosenberg SI, Silverstein H, Rowan PT, Olds MJEffect of melatonin on tinnitusLaryngoscope.(1998 Mar)
      232.^Megwalu UC, Finnell JE, Piccirillo JFThe effects of melatonin on tinnitus and sleepOtolaryngol Head Neck Surg.(2006 Feb)
      233.^Neri G, De Stefano A, Baffa C, Kulamarva G, Di Giovanni P, Petrucci G, Poliandri A, Dispenza F, Citraro L, Croce ATreatment of central and sensorineural tinnitus with orally administered Melatonin and Sulodexide: personal experience from a randomized controlled studyActa Otorhinolaryngol Ital.(2009 Apr)
      234.^Neri G, Baffa C, De Stefano A, Poliandri A, Kulamarva G, Di Giovanni P, Petrucci AG, Castriotta A, Citraro L, Cerrone D, D' Orazio F, Croce AManagement of tinnitus: oral treatment with melatonin and sulodexideJ Biol Regul Homeost Agents.(2009 Apr-Jun)
      235.^Zakian VATelomeres: beginning to understand the endScience.(1995 Dec 8)
      236.^Harley CB, Villeponteau BTelomeres and telomerase in aging and cancerCurr Opin Genet Dev.(1995 Apr)
      239.^Kirkpatrick KL, Clark G, Ghilchick M, Newbold RF, Mokbel KhTERT mRNA expression correlates with telomerase activity in human breast cancerEur J Surg Oncol.(2003 May)
      240.^Bayne S, Liu JPHormones and growth factors regulate telomerase activity in ageing and cancerMol Cell Endocrinol.(2005 Aug 30)
      242.^Martínez-Campa CM, Alonso-González C, Mediavilla MD, Cos S, González A, Sanchez-Barcelo EJMelatonin down-regulates hTERT expression induced by either natural estrogens (17beta-estradiol) or metalloestrogens (cadmium) in MCF-7 human breast cancer cellsCancer Lett.(2008 Sep 18)
      243.^Shay JW, Bacchetti SA survey of telomerase activity in human cancerEur J Cancer.(1997 Apr)
      244.^Reiter RJMechanisms of cancer inhibition by melatoninJ Pineal Res.(2004 Oct)
      245.^Leon-Blanco MM, Guerrero JM, Reiter RJ, Calvo JR, Pozo DMelatonin inhibits telomerase activity in the MCF-7 tumor cell line both in vivo and in vitroJ Pineal Res.(2003 Oct)
      247.^Vijayalaxmi, Thomas CR Jr, Reiter RJ, Herman TSMelatonin: from basic research to cancer treatment clinicsJ Clin Oncol.(2002 May 15)
      248.^Viswanathan AN, Schernhammer ESCirculating melatonin and the risk of breast and endometrial cancer in womenCancer Lett.(2009 Aug 18)
      249.^Srinivasan V, Spence DW, Pandi-Perumal SR, Trakht I, Esquifino AI, Cardinali DP, Maestroni GJMelatonin, environmental light, and breast cancerBreast Cancer Res Treat.(2008 Apr)
      250.^Korkmaz A, Sanchez-Barcelo EJ, Tan DX, Reiter RJRole of melatonin in the epigenetic regulation of breast cancerBreast Cancer Res Treat.(2009 May)
      254.^Stokkan KA, Reiter RJ, Nonaka KO, Lerchl A, Yu BP, Vaughan MKFood restriction retards aging of the pineal glandBrain Res.(1991 Apr 5)
      255.^Reiter RJThe melatonin rhythm: both a clock and a calendarExperientia.(1993 Aug 15)
      256.^Ferrari E, Cravello L, Falvo F, Barili L, Solerte SB, Fioravanti M, Magri FNeuroendocrine features in extreme longevityExp Gerontol.(2008 Feb)
      257.^Acuña-Castroviejo D, Carretero M, Doerrier C, López LC, García-Corzo L, Tresguerres JA, Escames GMelatonin protects lung mitochondria from agingAge (Dordr).(2011 May 26. {Epub ahead of print})
      259.^Forman K, Vara E, García C, Kireev R, Cuesta S, Escames G, Tresguerres JAEffect of a combined treatment with growth hormone and melatonin in the cardiological aging on male SAMP8 miceJ Gerontol A Biol Sci Med Sci.(2011 Aug)
      260.^Rodríguez MI, Carretero M, Escames G, López LC, Maldonado MD, Tan DX, Reiter RJ, Acuña-Castroviejo DChronic melatonin treatment prevents age-dependent cardiac mitochondrial dysfunction in senescence-accelerated miceFree Radic Res.(2007 Jan)
      261.^Forman K, Vara E, García C, Kireev R, Cuesta S, Acuña-Castroviejo D, Tresguerres JABeneficial effects of melatonin on cardiological alterations in a murine model of accelerated agingJ Pineal Res.(2010 Oct)
      262.^Tresguerres JA, Kireev R, Forman K, Cuesta S, Tresguerres AF, Vara EEffect of chronic melatonin administration on several physiological parameters from old wistar rats and samp8 miceCurr Aging Sci.(2012 Dec 1)
      263.^Cuesta S, Kireev R, García C, Forman K, Escames G, Vara E, Tresguerres JABeneficial effect of melatonin treatment on inflammation, apoptosis and oxidative stress on pancreas of a senescence accelerated mice modelMech Ageing Dev.(2011 Nov-Dec)
      264.^Cuesta S, Kireev R, Forman K, García C, Escames G, Ariznavarreta C, Vara E, Tresguerres JAMelatonin improves inflammation processes in liver of senescence-accelerated prone male mice (SAMP8)Exp Gerontol.(2010 Dec)
      268.^Tan DX, Reiter RJ, Manchester LC, Yan MT, El-Sawi M, Sainz RM, Mayo JC, Kohen R, Allegra M, Hardeland RChemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavengerCurr Top Med Chem.(2002 Feb)
      269.^Reiter RJ, Tan DX, Poeggeler B, Menendez-Pelaez A, Chen LD, Saarela SMelatonin as a free radical scavenger: implications for aging and age-related diseasesAnn N Y Acad Sci.(1994 May 31)
      270.^Kobayashi H, Kromminga A, Dunlop TW, Tychsen B, Conrad F, Suzuki N, Memezawa A, Bettermann A, Aiba S, Carlberg C, Paus RA role of melatonin in neuroectodermal-mesodermal interactions: the hair follicle synthesizes melatonin and expresses functional melatonin receptorsFASEB J.(2005 Oct)
      271.^Fischer TW, Slominski A, Tobin DJ, Paus RMelatonin and the hair follicleJ Pineal Res.(2008 Jan)
      272.^Fischer TW, Trüeb RM, Hänggi G, Innocenti M, Elsner PTopical melatonin for treatment of androgenetic alopeciaInt J Trichology.(2012 Oct)
      275.^Dragicevic N, Delic V, Cao C, Copes N, Lin X, Mamcarz M, Wang L, Arendash GW, Bradshaw PCCaffeine increases mitochondrial function and blocks melatonin signaling to mitochondria in Alzheimer's mice and cellsNeuropharmacology.(2012 Sep 1)
      276.^Ekman AC, Leppäluoto J, Huttunen P, Aranko K, Vakkuri OEthanol inhibits melatonin secretion in healthy volunteers in a dose-dependent randomized double blind cross-over studyJ Clin Endocrinol Metab.(1993 Sep)
      277.^Rupp TL, Acebo C, Carskadon MAEvening alcohol suppresses salivary melatonin in young adultsChronobiol Int.(2007)
      278.^Röjdmark S, Wikner J, Adner N, Andersson DE, Wetterberg LInhibition of melatonin secretion by ethanol in manMetabolism.(1993 Aug)
      279.^Hartman TJ, Mahabir S, Baer DJ, Stevens RG, Albert PS, Dorgan JF, Kesner JS, Meadows JW, Shields R, Taylor PRModerate alcohol consumption and 24-hour urinary levels of melatonin in postmenopausal womenJ Clin Endocrinol Metab.(2012 Jan)
      280.^Stevens RG, Davis S, Mirick DK, Kheifets L, Kaune WAlcohol consumption and urinary concentration of 6-sulfatoxymelatonin in healthy womenEpidemiology.(2000 Nov)
      281.^Walsh HA, Daya S, Whiteley CGMode of inhibition of rat liver tryptophan 2,3-dioxygenase by melatoninJ Pineal Res.(1994 May)
      283.^García-Mesa Y, Giménez-Llort L, López LC, Venegas C, Cristòfol R, Escames G, Acuña-Castroviejo D, Sanfeliu CMelatonin plus physical exercise are highly neuroprotective in the 3xTg-AD mouseNeurobiol Aging.(2012 Jun)
      285.^Ahmad A, Khan MM, Ishrat T, Khan MB, Khuwaja G, Raza SS, Shrivastava P, Islam FSynergistic effect of selenium and melatonin on neuroprotection in cerebral ischemia in ratsBiol Trace Elem Res.(2011 Jan)
      287.^Waldhauser F, Lieberman HR, Lynch HJ, Waldhauser M, Herkner K, Frisch H, Vierhapper H, Waldhäusl W, Schemper M, Wurtman RJ, et alA pharmacological dose of melatonin increases PRL levels in males without altering those of GH, LH, FSH, TSH, testosterone or cortisolNeuroendocrinology.(1987 Aug)
      288.^Valcavi R, Dieguez C, Azzarito C, Edwards CA, Dotti C, Page MD, Portioli I, Scanlon MFEffect of oral administration of melatonin on GH responses to GRF 1-44 in normal subjectsClin Endocrinol (Oxf).(1987 Apr)
      289.^Weinberg U, Weitzman ED, Horowitz ZD, Burg ACLack of an effect of melatonin on the basal and L-dopa stimulated growth hormone secretion in menJ Neural Transm.(1981)
      290.^Carr R, Wasdell MB, Hamilton D, Weiss MD, Freeman RD, Tai J, Rietveld WJ, Jan JELong-term effectiveness outcome of melatonin therapy in children with treatment-resistant circadian rhythm sleep disordersJ Pineal Res.(2007 Nov)
      291.^Lemoine P, Garfinkel D, Laudon M, Nir T, Zisapel NProlonged-release melatonin for insomnia - an open-label long-term study of efficacy, safety, and withdrawalTher Clin Risk Manag.(2011)
      292.^Pierrefiche G, Zerbib R, Laborit HAnxiolytic activity of melatonin in mice: involvement of benzodiazepine receptorsRes Commun Chem Pathol Pharmacol.(1993 Nov)
      293.^Golombek DA, Martini M, Cardinali DPMelatonin as an anxiolytic in rats: time dependence and interaction with the central GABAergic systemEur J Pharmacol.(1993 Jun 24)
      294.^Hoebert M, van der Heijden KB, van Geijlswijk IM, Smits MGLong-term follow-up of melatonin treatment in children with ADHD and chronic sleep onset insomniaJ Pineal Res.(2009 Aug)
      296.^Leibenluft E, Feldman-Naim S, Turner EH, Wehr TA, Rosenthal NEEffects of exogenous melatonin administration and withdrawal in five patients with rapid-cycling bipolar disorderJ Clin Psychiatry.(1997 Sep)
      297.^Wade AG, Ford I, Crawford G, McMahon AD, Nir T, Laudon M, Zisapel NEfficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomesCurr Med Res Opin.(2007 Oct)